<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">DH</journal-id><journal-title-group><journal-title>Dermatological Health</journal-title></journal-title-group><issn>3083-4775</issn><eissn>2981-8206</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/dh.v3i4.13676</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>The Impact of Intrinsic and External Environmental Factors on Treatment Efficacy in Patients with Chronic Spontaneous Urticaria: A Single-center Retrospective Study</title><url>https://artdesignp.com/journal/DH/3/4/10.26689/dh.v3i4.13676</url><author>LiSong,ChenAijun</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>3</volume><issue>4</issue><history><date date-type="pub"><published-time>2025-12-31</published-time></date></history><abstract>Purpose: This study aimed to explore the association between patient-intrinsic factors, environmental exposures, and improvement in psychosocial adaptation among individuals with chronic spontaneous urticaria (CSU). Methods: We conducted a single-center retrospective cohort study by reviewing medical records of 84 CSU patients aged 18–65 years who attended a tertiary dermatology outpatient clinic between January 2023 and January 2024, with follow-up of at least 3 months. Data on demographic characteristics, disease severity (measured by UCT score), and psychosocial adaptation (assessed via the Chinese version of the Patient Attitude and Self-Adaptation Questionnaire, PASQ-CSD) were extracted from electronic health records, while environmental variables—including monthly averages of temperature, humidity, PM2.5 levels, and pollen concentration—were obtained from national meteorological and environmental monitoring platforms. Improvement in psychosocial adaptation was defined as an increase of ≥5 points in PASQ score during 3–6 months of follow-up. Results: The mean age of participants was 44.27 ± 14.86 years, with 55.9% being female. Although no significant differences were observed in UCT scores (P = 0.402) or PARS-3 scores across treatment groups, PASQ scores showed statistically significant intergroup variation (P = 0.015). Occupational distribution differed significantly among groups (P = 0.034), whereas marital status did not (P = 0.219). No direct causal relationship was identified between medication type and psychological improvement; however, findings suggest that sociodemographic roles and environmental stressors may act as potential modifiers. Conclusion: These results indicate that psychosocial adaptation in CSU patients is influenced by multiple contextual factors, highlighting the need for integrated biopsychosocial assessment in clinical management and supporting future prospective studies on environment–psychology interactions.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Greiner B, Nicks S, Adame M, et al., 2022, Pathophysiology, diagnosis, and management of chronic spontaneous urticaria: a literature review. Clinical Reviews in Allergy &amp; Immunology, 63: 381-389.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Sánchez-Borges M, Ansotegui I J, Baiardini I, et al., 2021, The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management. World Allergy Organization Journal, 14(6): 100533.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Saini S S, Kaplan A P, 2018, Chronic spontaneous urticaria: The devil’s itch. The Journal of Al-lergy and Clinical Immunology: In Practice, 6: 1097-1106.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Donnelly J, Ridge K, O’Donovan R, et al., 2023, Psychosocial factors and chronic spontaneous urticaria: a systematic review. BMC Psychology, 11(1): 239.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Zheng Q, Zheng H, Zhou S, et al., 2022, Efficacy of acupuncture treatment for chronic sponta-neous urticaria: study protocol for a randomised controlled trial. BMJ Open, 12(2): e045027.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Zuberbier T, Aberer W, Asero R, et al., 2018, The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy, 73: 1393-1414.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Li S, Chen A, 2025, Validation of the reliability and validity of PSAQCSD, a psychosocial adap-tation assessment for patients with chronic urticaria. Dermatological Health, 3(2): 1-10.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Li C, Xie B, Duan R, et al., 2024, Clinical observation on the efficacy of omalizumab in the treatment of chronic urticaria. Journal of Dermatology and Venereology, 46(2): 108-111.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>He G Y, Tsai T F, Lin C L, et al., 2018, Association between sleep disorders and subsequent chronic spontaneous urticaria development. Medicine, 97(34): e11992.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Kocatürk E, Salameh P, Asero R, et al., 2025, Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights. Journal of the European Acad-emy of Dermatology and Venereology, 40: 67-78.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Stingeni L, Grieco T, Bonavita O, et al., 2025, Unmet needs and treatment patterns in Italian patients with chronic spontaneous urticaria: results from the Urticaria Voices study. Journal of Dermatological treatment, 36(1): 2566786.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Ashraf R, Bishnoi A, Mehta H, et al., 2024, Clinico-epidemiologic profile and response to levocetirizine in chronic spontaneous urticaria: a retrospective cohort study from a tertiary care center in north india. Indian Dermatology Online Journal, 15: 630-633.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Balp M M, Halliday A C, Severin T, et al., 2021, Clinical remission of chronic spontaneous urticaria (CSU): a targeted literature review. Dermatology and Therapy, 12: 15-27.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Choi W S, Lim E S, Ban G Y, et al., 2018, Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria. The Korean Journal of Internal Medicine, 33: 185-192.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Maurer M, Costa C, Gimenez Arnau A, et al., 2020, Antihistamine‐resistant chronic spontane-ous urticaria remains undertreated: 2‐year data from the AWARE study. Clinical &amp; Experimental Allergy, 50: 1166-1175.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
